Things are worsening for UnitedHealth Group (NYSE: UNH), with a significant drop in stock value—losing half its worth in 2025—amid poor financial results, a CEO change, and a Department of Justice investigation. Following a disappointing earnings report, the stock’s future remains uncertain, prompting questions about whether it is best to avoid or consider as a contrarian investment.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
